These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35189860)

  • 21. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women.
    Sánchez-Luceros A; Farías CE; Amaral MM; Kempfer AC; Votta R; Marchese C; Salviú MJ; Woods AI; Meschengieser SS; Lazzari MA
    Thromb Haemost; 2004 Dec; 92(6):1320-6. PubMed ID: 15583740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Von Willebrand factor, its cleaving protease (ADAMTS13), and inflammation in young adults: The African-PREDICT study.
    Möller C; Schutte AE; Smith W; Botha-Le Roux S
    Cytokine; 2020 Dec; 136():155265. PubMed ID: 32927287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.
    Zhao B; Li J; Luo X; Zhou Q; Chen H; Shi H
    Tex Heart Inst J; 2011; 38(5):516-22. PubMed ID: 22163125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.
    Takahashi N; Wada H; Usui M; Kobayashi T; Habe-Ito N; Matsumoto T; Uemoto S; Nobori T; Isaji S
    Thromb Res; 2013 Mar; 131(3):225-9. PubMed ID: 23266519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
    Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
    BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.
    Murphy SJX; Lim ST; Hickey F; Kinsella JA; Smith DR; Tierney S; Egan B; Feeley TM; Murphy SM; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; O'Donnell JS; O'Sullivan JM; Hamilton G; McCabe DJH
    Thromb Haemost; 2021 Jan; 121(1):86-97. PubMed ID: 32932544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H1N1 influenza (swine flu)-associated thrombotic microangiopathy with a markedly high plasma ratio of von Willebrand factor to ADAMTS13.
    Akiyama R; Komori I; Hiramoto R; Isonishi A; Matsumoto M; Fujimura Y
    Intern Med; 2011; 50(6):643-7. PubMed ID: 21422695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
    Béranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
    Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.
    Philippe A; Chocron R; Gendron N; Bory O; Beauvais A; Peron N; Khider L; Guerin CL; Goudot G; Levasseur F; Peronino C; Duchemin J; Brichet J; Sourdeau E; Desvard F; Bertil S; Pene F; Cheurfa C; Szwebel TA; Planquette B; Rivet N; Jourdi G; Hauw-Berlemont C; Hermann B; Gaussem P; Mirault T; Terrier B; Sanchez O; Diehl JL; Fontenay M; Smadja DM
    Angiogenesis; 2021 Aug; 24(3):505-517. PubMed ID: 33449299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU.
    De Jongh R; Ninivaggi M; Mesotten D; Bai C; Marcus B; Huskens D; Stragier H; Miszta A; Verbruggen J; de Laat-Kremers RMW; Grieten J; de Laat B
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):290-293. PubMed ID: 33443932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients.
    Martín-Rojas RM; Chasco-Ganuza M; Casanova-Prieto S; Delgado-Pinos VE; Pérez-Rus G; Duque-González P; Sancho M; Díez-Martín JL; Pascual-Izquierdo C
    Blood Coagul Fibrinolysis; 2021 Oct; 32(7):458-467. PubMed ID: 34310402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology.
    Stepanian A; Cohen-Moatti M; Sanglier T; Legendre P; Ameziane N; Tsatsaris V; Mandelbrot L; de Prost D; Veyradier A;
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1703-9. PubMed ID: 21512165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.
    Kumar M; Cao W; McDaniel JK; Pham HP; Raju D; Nawalinski K; Frangos S; Kung D; Zager E; Kasner SE; Levine JM; Zheng XL
    Thromb Haemost; 2017 Apr; 117(4):691-699. PubMed ID: 28102428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity.
    Dyer MR; Plautz WE; Ragni MV; Alexander W; Haldeman S; Sperry JL; Guyette FX; Zuckerbraun BS; Rollins-Raval MA; Raval JS; Neal MD;
    Transfusion; 2020 Jun; 60(6):1308-1318. PubMed ID: 32441353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
    Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
    Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia.
    Alpoim PN; Gomes KB; Godoi LC; Rios DR; Carvalho MG; Fernandes AP; Dusse LM
    Clin Chim Acta; 2011 Nov; 412(23-24):2162-6. PubMed ID: 21840304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.